Next Article in Journal
Advancing Brain Health Naturally: β-Caryophyllene and Xanthohumol as Neuroprotective Agents
Previous Article in Journal
Unlocking the Biochemical Potential of Diadema setosum Tests: A Pathway Toward Circular Marine Bioeconomy
Previous Article in Special Issue
Synthesis of Sucrose-Mimicking Disaccharide by Intramolecular Aglycone Delivery
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Carbohydrate Chemistry II

Institut des Biomolécules Max Mousseron (IBMM), University of Montpellier, 1919 Route de Mende, 34293 Montpellier, CEDEX 5, France
Molecules 2025, 30(18), 3701; https://doi.org/10.3390/molecules30183701
Submission received: 3 September 2025 / Accepted: 10 September 2025 / Published: 11 September 2025
(This article belongs to the Special Issue Carbohydrate Chemistry II)
This Special Issue on carbohydrates, including seven original articles and one review article, is mainly focused on the synthesis of mono, di and oligosaccharide derivatives. In particular, four articles described the preparation [1,2] and activation [3,4] of thioglycosides (S-glycosides), a well-known class of carbohydrates which can act as powerful glycosyl donors [5,6,7,8,9,10,11,12] or as chemically and enzymatically stable isosters of the natural O-glycosides [13,14,15]. Borbás, Herczeg and their co-workers reported on the multistep syntheses of thioglycosides of four l-hexopyranose, namely l-allose, l-galactose, l-gulose, and l-glucose, from a single very common sugar, the d-mannose [1]. These suitably protected glycosyl donors should provide a straightforward access to the complex, biologically active oligosaccharides and glycoconjugates bearing l-sugar units. A new activation protocol of thioglycoside glycosyl donors was reported by Demchenko and co-workers [3]. Although many efficient promoters were developed in recent years [10,16], these researchers found that CuBr2, a commercially available salt less expensive than copper(II) triflate, was able to activate the O-benzylated (“armed”) thioglycosides whereas the O-acylated (“disarmed”) glycosyl donors also required the presence of 0.5 equiv. of triflic acid. Exploiting their Cu-based protocol, various disaccharides could be prepared in good to excellent yield. Some special thioglycoside glycosyl donors were synthesised by Ando and co-workers and exploited to prepare biologically relevant di and trisaccharides [4]. In fact, they studied the effect of the protecting group at the C-4 position of 3-deoxy-d-manno-2-octulosonic acid (Kdo) α-d-thioglycosides bearing a macrocyclic chain between the carboxylic group (C-1) and the OH-5 function, thus blocking the β-face of the pyranose unit. These glycosyl donors allowed the efficient α-stereoselective glycosylation of primary and secondary sugar alcohols, a chemically and stereochemically challenging reaction due to the lack of anchimeric assistance (neighbouring group participation) and the presence of the strong electron-withdrawing carboxylic ester function [17,18]. Besides the use of thioglycosides as glycosyl donors, the article by Lafite, Daniellou and their co-workers demonstrated the biomedical importance of the S-glycosides by enzymatically synthesising a series of coumarin derivatives endowed with interesting fluorescence properties [2]. These new members of the mercapto-coumarin family [19], obtained via trans-glycosidation of p-nitrophenyl d-glycopyranosides with 7-mercapto-4-methylcoumarin, were found to be non-cytotoxic and potentially useful as imaging probes.
The present Special Issue also describes some synthetic approaches to carbohydrate derivatives mimicking natural mono, di and oligosaccharides. Aiming to obtain new ligands of a pathogenic Burkholderia cenocepacia lectin, Varrot, Bernardi and their co-workers designed, synthesised and tested unnatural, water-soluble anomeric amides of l-fucose and l-galactose that were found to be more active than the methyl O-fucoside monosaccharide [20]. These results confirmed that lectins are promising drug targets for anti-adhesion therapy, a powerful tool to prevent bacterial infections or to complement standard antibiotic treatments [21,22,23]. Ishiwata, Takeda and their co-workers prepared a disaccharide constituted of the rare sugars d-allose and d-psicose which mimics the d-sucrose (d-glucose linked to d-fructose), with the aim to replace the latter as a sweetener, thus suppressing the postprandial glucose elevation [24]. The desired α-d-allopyranosidic bond was stereoselectively obtained, taking advantage of the intramolecular aglycon delivery method [25,26,27]. Nifantiev and co-workers synthesised pseudodi, pseudotetra and pseudohexasaccharides structurally related to 1, 2 and 3 repeating units, respectively, of the Haemophilus influenza type a capsular glycan (Hia) [28]. The latter is a linear phosphoglycan featuring d-glucopyranoses β-linked to the d-ribitols. The new pseudosaccharides, obtained by iterative chain elongation using H-phosphonate chemistry [29], were equipped with a spacer which, in one case, was bearing a biotin unit in order to develop a probe for the detection of the Hia-associated invasive diseases.
A very important topic, i.e., the glycoconjugate vaccines, was examined in the long review article by Stefanetti and co-workers [30]. This class of vaccines is based on carbohydrate antigens covalently linked to a carrier protein, a feature that allows the sugar antigen to induce a long-lasting immunoglobulin G (IgG) antibody response [31,32,33,34]. The present review examined both the methods to size the polysaccharide antigens and the impact of the glycan chain length on the immunogenicity of the glycoconjugate vaccines based on preclinical and clinical evidence.

Funding

This research received no external funding.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Demeter, F.; Bereczki, I.; Borbás, A.; Herczeg, M. Synthesis of Four Orthogonally Protected Rare l-Hexose Thioglycosides from d-Mannose by C-5 and C-4 Epimerization. Molecules 2022, 27, 3422. [Google Scholar] [CrossRef]
  2. Burrini, N.; Pâris, A.; Collet, G.; Lafite, P.; Daniellou, R. Biocatalytic Synthesis of Coumarin S-Glycosides: Towards Non-Cytotoxic Probes for Biomedical Imaging and Sensing. Molecules 2024, 29, 1322. [Google Scholar] [CrossRef]
  3. Pooladian, F.; Escopy, S.; Demchenko, A.V. Activation of Thioglycosides with Copper(II) Bromide. Molecules 2022, 27, 7354. [Google Scholar] [CrossRef] [PubMed]
  4. Hamajima, S.; Komura, N.; Tanaka, H.-N.; Imamura, A.; Ishida, H.; Ichiyanagi, T.; Ando, H. Investigation of the Protection of the C4 Hydroxyl Group in Macrobicyclic Kdo Donors. Molecules 2023, 28, 102. [Google Scholar] [CrossRef] [PubMed]
  5. Garegg, P.J. Thioglycosides as Glycosyl Donors in Oligosaccharide Synthesis. Adv. Carbohydr. Chem. Biochem. 1997, 52, 179–205. [Google Scholar] [CrossRef]
  6. Oscarson, S. Thioglycosides. In Carbohydrates in Chemistry and Biology; Ernst, B., Hart, G.W., Sinaÿ, P., Eds.; Wiley-VCH: Weinheim, Germany; New York, NY, USA, 2000; Volume 1, pp. 93–116. [Google Scholar] [CrossRef]
  7. Codee, J.D.C.; Litjens, R.E.J.N.; van den Bos, L.J.; Overkleeft, H.S.; van der Marel, G.A. Thioglycosides in sequential glycosylation strategies. Chem. Soc. Rev. 2005, 34, 769–782. [Google Scholar] [CrossRef]
  8. Zhong, W.; Boons, G.-J. Glycoside synthesis from 1-sulfur/selenium-substituted derivatives: Thioglycosides in oligosaccharide synthesis. In Handbook of Chemical Glycosylation; Demchenko, A.V., Ed.; Wiley-VCH: Weinheim, Germany, 2008; pp. 261–303. [Google Scholar] [CrossRef]
  9. Lian, G.; Zhang, X.; Yu, B. Thioglycosides in Carbohydrate research. Carbohydr. Res. 2015, 403, 13–22. [Google Scholar] [CrossRef]
  10. Escopy, S.; Demchenko, A.V. Transition-Metal-Mediated Glycosylation with Thioglycosides. Chem. Eur. J. 2022, 28, e202103747. [Google Scholar] [CrossRef]
  11. Verma, N.; Cloutier, M.; Gauthier, C. Thioglycoside-based glycosylations in oligosaccharide synthesis. In Synthetic Strategies in Carbohydrate Chemistry; Tiwari, V.K., Ed.; Elsevier: Amsterdam, The Netherlands, 2024; pp. 95–138. [Google Scholar] [CrossRef]
  12. Gupta, S.; Gauthier, C. 1-Thiosugars: From Synthesis to Applications. Curr. Org. Chem. 2025, 29, 359–401. [Google Scholar] [CrossRef]
  13. Pachamuthu, K.; Schmidt, R.R. Synthetic Routes to Thiooligosaccharides and Thioglycopeptides. Chem. Rev. 2006, 106, 160–187. [Google Scholar] [CrossRef]
  14. Qiao, M.; Zhang, L.; Jiao, R.; Zhang, S.; Li, B.; Zhang, X. Chemical and enzymatic synthesis of S-linked sugars and glycoconjugates. Tetrahedron 2021, 81, 131920. [Google Scholar] [CrossRef]
  15. Xiong, T.; Xie, R.; Huang, C.; Lan, X.; Huang, N.; Yao, H. Recent advances in the synthesis of thiosugars using glycal donors. J. Carbohydr. Chem. 2021, 40, 401–439. [Google Scholar] [CrossRef]
  16. Zhang, Z.; Ollmann, I.R.; Ye, X.-S.; Wischnat, R.; Baasov, T.; Wong, C.-H. Programmable One-Pot Oligosaccharide Synthesis. J. Am. Chem. Soc. 1999, 121, 734–753. [Google Scholar] [CrossRef]
  17. Pradhan, T.K.; Mong, K.K.T. Glycosylation chemistry of 3-deoxy-d-manno-oct-2-ulosonic acid (Kdo) donors. Isr. J. Chem. 2015, 55, 285–296. [Google Scholar] [CrossRef]
  18. Kosma, P. Progress in Kdo-glycoside chemistry. Tetrahedron Lett. 2016, 57, 2133–2142. [Google Scholar] [CrossRef]
  19. El-Sawy, E.R.; Abdelwahab, A.B.; Kirsch, G. Insight on Mercapto-Coumarins: Synthesis and Reactivity. Molecules 2022, 27, 2150. [Google Scholar] [CrossRef]
  20. Mazzotta, S.; Antonini, G.; Vasile, F.; Gillon, E.; Lundstrøm, J.; Varrot, A.; Belvisi, L.; Bernardi, A. Identification of New l-Fucosyl and l-Galactosyl Amides as Glycomimetic Ligands of TNF Lectin Domain of BC2L-C from Burkholderia cenocepacia. Molecules 2023, 28, 1494. [Google Scholar] [CrossRef]
  21. Cozens, D.; Read, R.C. Anti-Adhesion Methods as Novel Therapeutics for Bacterial Infections. Expert Rev. Anti. Infect. Ther. 2012, 10, 1457–1468. [Google Scholar] [CrossRef]
  22. Krachler, A.M.; Orth, K. Targeting the Bacteria-Host Interface Strategies in Anti-Adhesion Therapy. Virulence 2013, 4, 284–294. [Google Scholar] [CrossRef]
  23. Damalanka, V.C.; Reddy Maddirala, A.; Janetka, J.W. Novel Approaches to Glycomimetic Design: Development of Small Molecular Weight Lectin Antagonists. Expert Opin. Drug Discov. 2021, 16, 513–536. [Google Scholar] [CrossRef]
  24. Sano, K.; Ishiwata, A.; Takamori, H.; Kikuma, T.; Tanaka, K.; Ito, Y.; Takeda, Y. Synthesis of Sucrose-Mimicking Disaccharide by Intramolecular Aglycone Delivery. Molecules 2024, 29, 1771. [Google Scholar] [CrossRef] [PubMed]
  25. Ishiwata, A.; Lee, Y.J.; Ito, Y. Recent Advances in Stereoselective Glycosylation through Intramolecular Aglycon Delivery. Org. Biomol. Chem. 2010, 8, 3596. [Google Scholar] [CrossRef]
  26. Jia, X.G.; Demchenko, A.V. Intramolecular Glycosylation. Beilstein. J. Org. Chem. 2017, 13, 2028–2048. [Google Scholar] [CrossRef]
  27. Cumpstey, I. Intramolecular Aglycon Delivery. Carbohydr. Res. 2008, 343, 1553–1573. [Google Scholar] [CrossRef]
  28. Kamneva, A.A.; Yashunsky, D.V.; Khatuntseva, E.A.; Nifantiev, N.E. Synthesis of Pseudooligosaccharides Related to the Capsular Phosphoglycan of Haemophilus influenzae Type a. Molecules 2023, 28, 5688. [Google Scholar] [CrossRef]
  29. Sobkowski, M.; Kraszewski, A.; Stawinski, J. Recent advances in H-phosphonate chemistry. Part 1. H-phosphonate esters: Synthesis and basic reactions. Top. Curr. Chem. 2015, 361, 137–177. [Google Scholar] [CrossRef]
  30. Stefanetti, G.; MacLennan, C.A.; Micoli, F. Impact and Control of Sugar Size in Glycoconjugate Vaccines. Molecules 2022, 27, 6432. [Google Scholar] [CrossRef]
  31. Ravenscroft, N.; Jones, C. Glycoconjugate vaccines. Curr. Opin. Drug Discov. Dev. 2000, 3, 222–231. [Google Scholar]
  32. Khatun, F.; Stephenson, R.J.; Toth, I. An overview of structural features of antibacterial glycoconjugate vaccines that influence their immunogenicity. Chem. Eur. J. 2017, 23, 4233–4254, Erratum in Chem. Eur. J. 2017, 23, 6458. https://doi.org/10.1002/chem.201701478. [Google Scholar] [CrossRef]
  33. Rappuoli, R.; De Gregorio, E.; Costantino, P. On the mechanisms of conjugate vaccines. Proc. Natl. Acad. Sci. USA 2019, 116, 14–16. [Google Scholar] [CrossRef] [PubMed]
  34. Del Bino, L.; Østerlid, K.E.; Wu, D.Y.; Nonne, F.; Romano, M.R.; Codée, J.; Adamo, R. Synthetic glycans to improve current glycoconjugate vaccines and fight antimicrobial resistance. Chem. Rev. 2022, 122, 15672–15716. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Marra, A. Carbohydrate Chemistry II. Molecules 2025, 30, 3701. https://doi.org/10.3390/molecules30183701

AMA Style

Marra A. Carbohydrate Chemistry II. Molecules. 2025; 30(18):3701. https://doi.org/10.3390/molecules30183701

Chicago/Turabian Style

Marra, Alberto. 2025. "Carbohydrate Chemistry II" Molecules 30, no. 18: 3701. https://doi.org/10.3390/molecules30183701

APA Style

Marra, A. (2025). Carbohydrate Chemistry II. Molecules, 30(18), 3701. https://doi.org/10.3390/molecules30183701

Article Metrics

Back to TopTop